Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.medscape.com/viewarticle/983907
0
0
SGLT2 Inhibitors Safe After Revascularization for Limb Disease - Medscape
11/11/22 at 2:50pm
Organization
Medscape
Authors
Miriam E. Tucker
for Medscape
Details
37 words
Summarize
Health Conditions
Health
SGLT2 Inhibitors Safe After Revascularization for Limb Disease
Medscape
limb amputation
In patients with type 2 diabetes and peripheral artery disease who undergo revascularization, cardiovascular and renal benefits of the agents were confirmed without increased risk of limb amputation.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...